Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study.

No Thumbnail Available

Date

2021-11

Authors

Perez-Belmonte, Luis M
Sanz-Canovas, Jaime
Salinas, Alejandro
Sagastagoitia-Fornie, Iñigo
Mendez-Bailon, Manuel
Gomez-Huelgas, Ricardo

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Milano
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The efficacy of corticosteroid use in COVID-19 has been widely debated [1]. Although corticosteroids were found to be associated with improved clinical outcomes in severely ill patients in a recent systematic review and meta-analysis of randomized clinical trials, the sequential analysis suggested a need for further research to confirm these results [2].

Description

MeSH Terms

Adrenal Cortex Hormones
Aged
COVID-19
Critical Care
Female
Heart Failure
Hospital Mortality
Humans
Hydroxychloroquine
Length of Stay
Male
Middle Aged
Retrospective Studies
Severity of Illness Index
COVID-19 Drug Treatment

DeCS Terms

COVID-19
Hormonas de la corteza suprarrenal
Glucocorticoides
Antiinflamatorios
Síndrome respiratorio agudo grave por coronavirus 2
Enfermedad crítica
Resultado del tratamiento
Práctica clínica basada en la evidencia

CIE Terms

Keywords

COVID-19, Corticosteroid therapy, Severe illness, Clinical outcomes, Systematic review, Meta-analysis, Sequential analysis, Evidence gaps, Critical care

Citation

Pérez-Belmonte LM, Sanz-Cánovas J, Salinas A, Fornie IS, Méndez-Bailón M, Gómez-Huelgas R; et al. Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study. Intern Emerg Med. 2021 Nov;16(8):2301-2305.